# Role of aGVHD Biomarkers on aGVHD Risks

> **NCT04284904** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 500 (actual)

## Conditions studied

- GVHD,Acute
- Biomarker

## Interventions

- **DIAGNOSTIC_TEST:** aGVHD biomarker

## Key facts

- **NCT ID:** NCT04284904
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04284904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04284904, "Role of aGVHD Biomarkers on aGVHD Risks". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04284904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*